McCourt K C, Salmela L, Mirakhur R K, Carroll M, Mäkinen M T, Kansanaho M, Kerr C, Roest G J, Olkkola K T
Department of Anaesthetics, Queen's University of Belfast, UK.
Anaesthesia. 1998 Sep;53(9):867-71. doi: 10.1046/j.1365-2044.1998.00342.x.
This study was designed to compare the tracheal intubating conditions during a rapid sequence induction of anaesthesia using rocuronium 0.6 (n = 61) or 1.0 mg.kg-1 (n = 130) or suxamethonium 1.0 mg.kg-1 (n = 127) as the neuromuscular blocking drugs. Anaesthesia was induced with fentanyl 1-2 micrograms.kg-1 and thiopentone 5 mg.kg-1 (median dose) and intubating conditions were assessed 60s after the administration of the neuromuscular blocking drug by an observer unaware of which drug had been given. Intubating conditions were graded on a three-point scale as excellent, good or poor, the first two being considered clinically acceptable. The study was carried out in two parts. At the end of the first part a comparison between the two doses of rocuronium was carried out when at least 50 patients had been enrolled in each group. The results showed the intubating conditions to be significantly superior with the 1.0 mg.kg-1 dose of rocuronium (p < 0.01). Final comparison between the 1.0 mg.kg-1 doses of rocuronium and suxamethonium showed no significant difference in the incidence of acceptable intubations (96 and 97%, respectively). The incidence of excellent grade of intubations was, however, significantly higher with suxamethonium (80% vs. 65%; p = 0.02). It is concluded that rocuronium 1.0 mg.kg-1 can be used as an alternative to suxamethonium 1.0 mg.kg-1 as part of a rapid sequence induction provided there is no anticipated difficulty in intubation. The clinical duration of this dose of rocuronium is, however, 50-60 min.
本研究旨在比较在快速顺序诱导麻醉期间,使用0.6毫克(n = 61)或1.0毫克/千克(n = 130)罗库溴铵或1.0毫克/千克琥珀胆碱(n = 127)作为神经肌肉阻滞药物时的气管插管条件。麻醉诱导采用1 - 2微克/千克芬太尼和5毫克/千克(中位剂量)硫喷妥钠,在给予神经肌肉阻滞药物60秒后,由不知道给予何种药物的观察者评估插管条件。插管条件按三点量表分为优、良或差,前两者被认为临床可接受。该研究分两部分进行。在第一部分结束时,当每组至少招募50名患者时,对两种剂量的罗库溴铵进行了比较。结果显示,1.0毫克/千克剂量的罗库溴铵插管条件明显更优(p < 0.01)。罗库溴铵1.0毫克/千克剂量与琥珀胆碱的最终比较显示,可接受插管的发生率无显著差异(分别为96%和97%)。然而,琥珀胆碱的优级插管发生率显著更高(80%对65%;p = 0.02)。结论是,只要预计插管无困难,1.0毫克/千克罗库溴铵可作为1.0毫克/千克琥珀胆碱的替代品用于快速顺序诱导的一部分。然而,该剂量罗库溴铵的临床作用时间为50 - 60分钟。